2022
DOI: 10.3390/mi13030428
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro

Abstract: Mortality from liver disease conditions continues to be very high. As liver diseases manifest and progress silently, prompt measures after diagnosis are essential in the treatment of these conditions. Microfluidic organs-on-chip platforms have significant potential for the study of the pathophysiology of liver diseases in vitro. Different liver-on-a-chip microphysiological platforms have been reported to study cell-signaling pathways such as those activating stellate cells within liver diseases. Moreover, the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(18 citation statements)
references
References 109 publications
(158 reference statements)
0
18
0
Order By: Relevance
“…Several studies have been published in recent years for Liver-on-a-chip applications underlining the great potential showed to replace animal experiments for drug testing and liver disease modelling although there are still some existing challenges to address [ 64 , 65 , 66 ]. The design of the biochip described demonstrated their potential for the cultures of different hepatic cells including HepG2/C3A, primary rat and human hepatocytes and induced pluripotent stem cells (hiPSCs) in PDMS material [ 18 , 38 , 56 , 67 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have been published in recent years for Liver-on-a-chip applications underlining the great potential showed to replace animal experiments for drug testing and liver disease modelling although there are still some existing challenges to address [ 64 , 65 , 66 ]. The design of the biochip described demonstrated their potential for the cultures of different hepatic cells including HepG2/C3A, primary rat and human hepatocytes and induced pluripotent stem cells (hiPSCs) in PDMS material [ 18 , 38 , 56 , 67 ].…”
Section: Discussionmentioning
confidence: 99%
“…Since liver diseases manifest and develop silently, it is vital to immediately take action following a diagnosis [ 315 ]. In vitro studies of the pathogenesis of liver disorders benefit from microfluidic disease-on-chip technologies [ 315 ]. Numerous liver disease-on-a-chip systems have been introduced, particularly for investigating fatty liver disease.…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…Furthermore, investigations of chemical syntheses in various microreactors configurations may also represent an important base for designing chips for other purposes. Specifically, fluid dynamics analyses may be of good use for researchers aiming to fabricate microfluidic platforms for emerging biomedical applications, including non-invasive diagnosis devices [ 108 , 109 , 110 , 111 , 112 ], cell culture media (organs-on-a-chip) [ 113 , 114 , 115 , 116 , 117 ], and precise drug-delivery systems [ 118 , 119 , 120 , 121 ].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%